drugset / Trial / NCT05294679

Explore the Clinical Application Value of Ciprofol in Painless Colonoscopy

NCT05294679

Completed 110 enrolled Sichuan Provincial People's Hospital
RandomizedParallel-groupDouble-blindTreatment

Summary

This study used propofol as a positive control, and adopted a large-sample, multi-center, randomized, double-blind, positive parallel controlled trial design to explore the clinical application value of ciprofol in painless colonoscopy.

Timeline

Start
2022-06-01
Primary completion
2022-12-01
Completion
2023-04-30

Drugs

EvaluationDrugModalityDoseRoute
Subject Cipepofol Small molecule 0.1 mg/kg Intravenous
Comparator Propofol Small molecule 0.5 mg/kg Intravenous

Indications

No indication recorded.